Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PHVS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Pharvaris B.V. stock price ended at $24.57 on Wednesday, after losing 0.0813%.
(Updated on May 01, 2024)

Buy or Hold candidate since Apr 25, 2024 Gain 7.91% PDF

The Pharvaris B.V. stock price fell by -0.0813% on the last day (Wednesday, 1st May 2024) from $24.59 to $24.57. During the last trading day the stock fluctuated 8.64% from a day low at $23.16 to a day high of $25.16. The price has risen in 7 of the last 10 days and is up by 15.9% over the past 2 weeks. Volume has increased on the last day by 47 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 114 thousand shares were bought and sold for approximately $2.80 million.

Given the current short-term trend, the stock is expected to fall -24.37% during the next 3 months and, with a 90% probability hold a price between $13.05 and $18.58 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PHVS Signals & Forecast

The Pharvaris B.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $23.04 and $22.65. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 33.39%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Pharvaris B.V. stock

Pharvaris B.V. finds support from accumulated volume at $23.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.00 between high and low, or 8.64%. For the last week, the stock has had daily average volatility of 11.99%.

Our recommended stop-loss: $23.88 (-2.82%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (PHVS) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Pharvaris B.V. to open at $24.30, and during the day (based on 14 day Average True Range), to move between $22.42 and $26.72, which gives a possible trading interval of +/-$2.15 (+/-8.73%) up or down from last closing price. If Pharvaris B.V. takes out the full calculated possible swing range there will be an estimated 17.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $23.35 (4.97%) than the resistance at $26.69 (8.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pharvaris B.V. stock A Buy?

Pharvaris B.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Pharvaris B.V. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$24.30 ( 1.11%) $24.57

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PHVS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 26.30 7.03 %
R2 25.53 3.92 %
R1 25.06 2.00 %
Current price: 24.57
Support S1 23.53 -4.22 %
S2 23.06 -6.14 %
S3 22.30 -9.25 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 29.53 20.19 %
R2 28.87 17.50 %
R1 26.69 8.63 %
Current price 24.57
Support S1 23.35 -4.97%
S2 23.23 -5.45%
S3 21.20 -13.72%

FAQ

What is the symbol for Pharvaris B.V. Stock and on which exchange is it traded?
The symbol for Pharvaris B.V. is PHVS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pharvaris B.V. Stock?
Pharvaris B.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Pharvaris B.V. Stock?
Pharvaris B.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharvaris B.V. Stock.

What's the current price of Pharvaris B.V. Stock?
As of the end of day on the May 01, 2024, the price of an Pharvaris B.V. (PHVS) share was $24.57.

What is the 52-week high and low for Pharvaris B.V. Stock?
The 52-week high for Pharvaris B.V. Stock is $33.00 and the 52-week low is $7.93.

What is the market capitalization of Pharvaris B.V. Stock?
As of the May 01, 2024, the market capitalization of Pharvaris B.V. is 1.322B.

When is the next earnings date for Pharvaris B.V.?
The upcoming earnings date for Pharvaris B.V. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT